HCV core protein modulates the immune response against the HBV surface antigen in mice
Julio Aguilar(Centro de Ingeniería Genética y Biotecnología), Verena Muzio(Centro de Ingeniería Genética y Biotecnología), Dagmara Pichardo(Centro de Ingeniería Genética y Biotecnología), Nelson Acosta‐Rivero(University of Havana), Gerardo Guillén(Hunan City University), Santiago Dueñas‐Carrera(Centro de Ingeniería Genética y Biotecnología), Juan Morales Grillo(Centro de Ingeniería Genética y Biotecnología), Dioslaida Urquiza(Centro de Ingeniería Genética y Biotecnología)
Cited by 10
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
|Frontiers in Endocrinology|2020|134